Primary Ciliary Dyskinesia
Conditions
Brief summary
This is a study evaluating the utility of current Primary Ciliary Dyskinesia (PCD) diagnostic tests, including nasal nitric oxide testing.
Detailed description
This study is a prospective data collection of individuals referred to the investigators clinical center for considerations of PCD. Participants sign informed consent to have clinical information entered into a secure electronic database. As part of this study, participants may have nasal nitric oxide (nNO) testing performed. nNO testing is a research procedure, but it is a test with growing utility for making a diagnosis of PCD when performed in the right clinical setting.
Interventions
OTHERnNO testing
Collection of already performed clinical data and nNO testing
Sponsors
Vanderbilt University Medical Center
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
1 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Referred to center for PCD diagnosis considerations * Ability to perform study procedures * Age greater than 2 years of age
Exclusion criteria
* Age less than 2 years of age Inability to perform informed consent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| frequency of nNO tests performed | 3 years | number of tests |
| Frequency of genetic tests performed | 3 years | number of tests |
Countries
United States
Contacts
CONTACTMichael O'Connor, MD
Outcome results
None listed